Cargando…
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
The COVID-19 pandemic has wreaked unprecedented societal havoc worldwide. The infected individuals may present mild to severe symptoms, with nearly 20% of the confirmed patients impaired with significant complications, including multi-organ failure. Acute respiratory distress imposed by SARS-CoV-2 l...
Autores principales: | Cheema, Pradeep Singh, Nandi, Deeptashree, Nag, Alo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187014/ https://www.ncbi.nlm.nih.gov/pubmed/34102081 http://dx.doi.org/10.1098/rsob.210069 |
Ejemplares similares
-
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
por: Nandi, Deeptashree, et al.
Publicado: (2021) -
Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond
por: Chand, Vaibhav, et al.
Publicado: (2016) -
Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009) -
The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus
por: Marchelek-Mysliwiec, Malgorzata, et al.
Publicado: (2022) -
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity
por: Bharti, Hina, et al.
Publicado: (2022)